Decoding myofibroblast origins in human kidney fibrosis
Kidney fibrosis is the hallmark of chronic kidney disease progression; however, at present no antifibrotic therapies exist
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 January 2021
|
| In: |
Nature
Year: 2021, Volume: 589, Pages: 281-286 |
| ISSN: | 1476-4687 |
| DOI: | 10.1038/s41586-020-2941-1 |
| Online Access: | Resolving-System, lizenzpflichtig: http://dx.doi.org/10.1038/s41586-020-2941-1 |
| Author Notes: | Christoph Kuppe, Mahmoud M. Ibrahim, Jennifer Kranz, Xiaoting Zhang, Susanne Ziegler, Javier Perales-Patón, Jitske Jansen, Katharina C. Reimer, James R. Smith, Ross Dobie, John R. Wilson-Kanamori, Maurice Halder, Yaoxian Xu, Nazanin Kabgani, Nadine Kaesler, Martin Klaus, Lukas Gernhold, Victor G. Puelles, Tobias B. Huber, Peter Boor, Sylvia Menzel, Remco M. Hoogenboezem, Eric M. J. Bindels, Joachim Steffens, Jürgen Floege, Rebekka K. Schneider, Julio Saez-Rodriguez, Neil C. Henderson, Rafael Kramann |
| Summary: | Kidney fibrosis is the hallmark of chronic kidney disease progression; however, at present no antifibrotic therapies exist |
|---|---|
| Item Description: | Gesehen am 02.05.2024 Online veröffentlicht: 11 November 2020 |
| Physical Description: | Online Resource |
| ISSN: | 1476-4687 |
| DOI: | 10.1038/s41586-020-2941-1 |